Smart Cold
Smart Cold, licence 80076508: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Zollaris Laboratories Corporation
- NPN or DIN-HM
- 80076508
- Status
- Inactive licence
- Licence date
- 4 April 2017
- Revision date
- 21 October 2021
- Form
- Vaporisateur
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| l-Menthol Source : Mentha X piperita - feuille | 8.0 Pour cent | Not calculated |
Non-medicinal ingredients
Extrait de feuilles d'Eucalyptus globulus, Butylène glycol, Eau, Alcool éthylique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2.0 Année(s) | Not specified | Not specified |
Uses authorised in Canada
Soulage temporairement la douleur et les courbatures des muscles et des articulations associée(s) à une ou plusieurs des conditions suivantes : mal de dos, lumbago, contusions, foulure/entorse (impliquant les muscles, les tendons, et/ou les ligaments), et la douleur arthritique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Une sensation d'irritation et/ou de brûlement peut survenir; dans ce cas, cesser l'utilisation. Une hypersensibilité peut survenir; dans ce cas, cesser l'utilisation.
- Précautions et mises en garde
Garder hors de portée des enfants. En cas de surdosage ou d'ingestion accidentelle, appeler un Centre Antipoison immédiatement. Si les symptômes persistent et/ou s'aggravent après 7 jours ou si les symptômes reviennent après quelques jours, cesser l'utilisation et consulter un praticien de soins de santé. Si vous êtes enceinte ou allaitez, consulter un praticien de soins de santé avant d'en faire l'usage.
- Contre-indications
Énoncé non requis.
Source
Official Health Canada record, licence 80076508
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.